日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01

Zanidatamab治疗HER2阳性转移性胆道癌:HERIZON-BTC-01研究的最终结果

Pant, Shubham; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Macarulla, Teresa; Xie, Feng; Metges, Jean-Phillippe; Ying, Jie'er; Bridgewater, John; Lee, Myung-Ah; Tejani, Mohamedtaki A; Chen, Emerson Y; Wasan, Harpreet; Ducreux, Michel; Bao, Yuanyuan; Wu, Xiaotian; Zhao, Yi; Garfin, Phillip M; Gable, Jonathon; Harding, James J

Author Correction: DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B

作者更正:DKN-01 和替雷利珠单抗作为 DKK1 高表达胃食管腺癌二线治疗:DisTinGuish 试验 B 部分

Lee, Keun-Wook; Mahalingam, Devalingam; Shim, Byoung Yong; Kim, In-Ho; Oh, Do-Youn; Uronis, Hope; Sym, Sun Jin; Sonbol, Mohamad; Almhanna, Khaldoun; Tejani, Mohamedtaki A; Kang, Beodeul; Kagey, Michael H; Stilian, Melissa; Jia, Calvin; Sirard, Cynthia A; Altura, Rachel; Ajani, Jaffer A; Klempner, Samuel J

First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers

RO7119929(一种口服TLR7激动剂前药)在晚期原发性或转移性肝癌患者中的首次人体I期研究

Yoo, Changhoon; Fabregat-Franco, Carles; Lin, Chia-Chi; Qvortrup, Camilla; Oh, Do-Youn; Yau, Thomas; Kim, Hyung-Don; Castet, Florian; Ponz Sarvise, Mariano; Hsu, Chiun; Rohrberg, Kristoffer Staal; Lichtenegger, Felix Sebastian; Franjkovic, Izolda; Kratochwil, Nicole A; Bessa, Juliana; Rossmann, Eva; Schwalie, Petra C; Rieder, Natascha; Pöschinger, Thomas; Sie, Christina Godfried; Dettling, Steffen; Schlenker, Ramona; Jiang, Tianyi; Dai, Congqi; Yun, Hongying; Hall, Elia; Yeo Te-Ying, Audrey; Hoves, Sabine; Cannarile, Michael A; Schiff, Christina; Sangro, Bruno

Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma

Zanidatamab联合Tislelizumab和化疗一线治疗HER2阳性胃/胃食管交界处腺癌的Ib/II期研究

Lee, Keun-Wook; Bai, Li-Yuan; Jung, Minkyu; Ying, Jieer; Im, Young-Hyuck; Oh, Do-Youn; Cho, Jae Yong; Oh, Sang Cheul; Chao, Yee; Kim, Jin Won; Chen, Ye; Li, Vincent; Chen, Shengnan; Kang, Yoon-Koo

MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response

MAPK通路突变出现在对IDH1抑制剂耐药的胆管癌中,并减弱IFN反应

Wan, Jinkai; Saatcioglu, Hatice Duygu; Ellis, Haley; Aguado-Fraile, Elia; Xu, Qin; Kondo, Hiroshi; Manguso, Robert T; Gritti, Ilaria; Norden, Bryanna L; Noble, Carolina; Corcoran, Ryan B; Lubner, Sam J; Javle, Milind; Abou-Alfa, Ghassan K; Cleary, James M; Kelley, Robin K; Borad, Mitesh J; Macarulla, Teresa; Oh, Do Youn; Daigle, Scott; Gliser, Camelia; Pandya, Susan; Choe, Sung; Tron, Adriana E; Bardeesy, Nabeel

Controlled-release nanoparticle of toll-like receptors-7/8 agonist enhances immune activation and inhibits gastric cancer in a preclinical mouse model.

可控释放的 Toll 样受体 7/8 激动剂纳米颗粒可增强免疫激活,并在临床前小鼠模型中抑制胃癌。

Kim Hyun Myong, Jeong Kyoungyun, Jeong Juhee, Jin Seung Mo, Yoo Jaeun, Yoo Yie-Ri, Shin Ji-Yeon, Park Do Joong, Lee Hyuk-Joon, Yang Han-Kwang, Lee Hye Seung, Oh Do-Youn, Lim Yong Taik, Jung Keehoon, Kong Seong-Ho

Traditional Korean Doenjang Restores Splenic and NK Cell Function in Cyclophosphamide-Induced Immunosuppressed Rats.

传统韩国大酱可恢复环磷酰胺诱导的免疫抑制大鼠的脾脏和NK细胞功能。

Lee Hak Yong, Park Young Mi, Shin Dong Yeop, Hwang Hai Min, Chun Sung Hak, Lim Sang Jin, Yang Hee-Jong, Ha Gwang Su, Ryu Myeong Seon, Seo Ji Won, Jeong Do-Youn, Bae Jun Sang, Kim Jae Gon

Neurocysticercosis in transition: expanding clinical spectrum, evolving diagnostics, and emerging therapies

神经囊虫病正处于变革之中:临床表现谱不断扩大,诊断方法不断发展,治疗方法日趋成熟

Lee, Do-Youn; Mantravadi, Hima Bindu; Puri, Dinesh; Gupta, Amit Kumar; Sonje, Preeti Dnyandeo; Lakhanpal, Sorabh; Singh, Sujeet Kumar; Kumar, Sanjay; Jaison, Karen

Predictors of overall survival in advanced biliary tract cancer in the phase 3 TOPAZ-1 study

TOPAZ-1 3期研究中晚期胆道癌患者总生存期的预测因素

He, Aiwu R; Bouattour, Mohamed; Gupta, Vineet G; Evesque, Ludovic; Zhen, David B; Park, Joon Oh; Sookprasert, Aumkhae; Salvatierra, Alejandro; Vaccaro, Gina; Oh, Sang Cheul; Ostoich, Sandra Anabel; Satoh, Taroh; Kuzko, Aleksandra; Żotkiewicz, Magdalena; Rokutanda, Nana; Oh, Do-Youn

Atezolizumab and motixafortide, cobimetinib or simlukafusp alfa in pretreated advanced pancreatic cancer: phase I/IIb MORPHEUS-PDAC umbrella study

阿特珠单抗联合莫替沙福肽、考比替尼或西卢卡福司α治疗既往接受过治疗的晚期胰腺癌:I/IIb期MORPHEUS-PDAC伞状研究

Manji, Gulam A; Chung, Vincent; Oh, Do-Youn; Lacy, Jill; Lopez, Charles D; Ponz-Sarvisé, Mariano; Macarulla, Teresa; Thomas, Roby; George, Ben; Alistar, Angela; Siveke, Jens T; Xu, Yun; Lau, Janet; Cha, Edward; Kim, Kyu-Pyo; O'Reilly, Eileen M